Health TrialsbyHealthPanel

Immediate Postpartum Glucose Tolerance Testing

ConditionGestational Diabetes
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorMemorialCare Health System

About this trial

The objective of this study is to compare the accuracy of a 2hr glucose tolerance test administered during the postpartum hospitalization with the standard of care glucose tolerance testing (administered at 6 weeks postpartum). The primary hypothesis is that the glucose tolerance test administered in the postpartum period will be accurate and will improve compliance with postpartum testing for gestational diabetics.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Pregnant or recently postpartum (postpartum day 0 or 1)

≥ 18 years of age

Gestational age ≥34 weeks

A1 or A2 gestational diabetes

Disqualifiers

Medical exclusion from completing glucose tolerance testing

Steroid administration within 10 days prior to enrollment

Chronic steroid use

Trial population

All individual diagnosed with gestational diabetes will be approached following admission to labor and delivery and invited to participate.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Glucose tolerance test

    Diagnostic test

    Oral administration of a 75g glucose tolerance test during the postpartum hospitalization

Treatment groups

300 Participants
are divided into 1 treatment group
Group A: Intervention1 intervention

Trial outcomes

Primary outcomes

1

Accuracy of immediate glucose tolerance testing

Diagnostic accuracy between immediate postpartum glucose tolerance testing and gold standard testing

Time frame
6-12 weeks postpartum

Secondary outcomes

1

Compliance with standard glucose tolerance testing

Percentage of the cohort that comply with glucose tolerance testing at their postpartum visit

Time frame
12 weeks postpartum
2

Transition to primary care

Percentage of cohort that are appropriately referred to ongoing primary care

Time frame
12 weeks postpartum

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

MemorialCare Health System

Lead sponsor

Source ClinicalTrials.gov
Apply now